State of Wisconsin Investment Board’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
29,889
+7,579
+34% +$662K 0.01% 1337
2026
Q1
$1.87M Buy
22,310
+6,135
+38% +$355K ﹤0.01% 1427
2025
Q4
$667K Buy
16,175
+8,927
+123% +$346K ﹤0.01% 1819
2025
Q3
$285K Sell
7,248
-10,761
-60% -$275K ﹤0.01% 2135
2025
Q2
$336K Buy
18,009
+5,329
+42% +$100K ﹤0.01% 2021
2025
Q1
$230K Sell
12,680
-346
-3% -$7.63K ﹤0.01% 2065
2024
Q4
$284K Buy
13,026
+4,370
+50% +$112K ﹤0.01% 2024
2024
Q3
$237K Buy
+8,656
New +$241K ﹤0.01% 2121
2021
Q4
Sell
-1,644
Closed -$191K 2169
2021
Q3
$191K Hold
1,644
﹤0.01% 2077
2021
Q2
$257K Hold
1,644
﹤0.01% 2003
2021
Q1
$311K Hold
1,644
﹤0.01% 1854
2020
Q4
$206K Sell
1,644
-206
-11% -$23.4K ﹤0.01% 1944
2020
Q3
$201K Sell
1,850
-525
-22% -$62.2K ﹤0.01% 1910
2020
Q2
$285K Buy
2,375
+106
+5% +$14.9K ﹤0.01% 1568
2020
Q1
$228K Buy
2,269
+444
+24% +$82.3K ﹤0.01% 1555
2019
Q4
$443K Hold
1,825
﹤0.01% 1475
2019
Q3
$300K Buy
1,825
+519
+40% +$98.6K ﹤0.01% 1448
2019
Q2
$308K Buy
+1,306
New +$323K ﹤0.01% 1438

Other funds holding DNTH

State of Wisconsin Investment Board's DNTH Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Dianthus Therapeutics (DNTH) stake by 34% in Q2 2026, buying an estimated $662K and bringing the position to 29,889 shares worth $2.91M. The position accounts for 0.01% of the portfolio, ranked #1337.

State of Wisconsin Investment Board first reported a position in DNTH in Q2 2019 and has held it in 18 quarters since. 268 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • State of Wisconsin Investment Board held 29,889 shares of Dianthus Therapeutics worth $2.91M as of Q2 2026.
  • State of Wisconsin Investment Board bought 7,579 Dianthus Therapeutics shares in Q2 2026, an estimated $662K.
  • Dianthus Therapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1337 holding.
  • State of Wisconsin Investment Board first reported a position in Dianthus Therapeutics in Q2 2019 and has held it in 18 quarters since.
  • 268 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.